Printer Friendly

Syngenta obtains United States patent.

Syngenta Participations AG (Basel, Switzerland) has patented the Arabidopsis NI16 gene isolated in a yeast 2-hybrid screen via its interaction with the NIM1 protein. The NI16 gene encodes a protein involved in the regulation of SAR gene expression in plants. NI16 is strongly induced in NIM1-overexpressing plants treated with benzo(1,2,3)thiadiazole-7-carbothioic acid S-methyl ester. The NIMI interactor can be expressed in transgenic plants, either alone or in combination with the NIMI protein, to increase expression of SAR genes such as PR-1. (US 6,706,952)
COPYRIGHT 2004 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Syngenta Participations AG
Comment:Syngenta obtains United States patent.(Syngenta Participations AG)
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:4EXSI
Date:Mar 1, 2004
Words:88
Previous Article:Diversa obtains United States patent.
Next Article:New York University obtains United States patent.
Topics:


Related Articles
Diversa announces issuance of patent reinforcing rights for discovery of enzymes.
Syngenta obtains United States patent.
Syngenta obtains United States patent.
Sterile harvest: New Crop of Terminator patents threatens food Sovereignty. (Thinking Economically).
Patent expands Diversa's gene evolution portfolio.
Swiss biotech giant Syngenta has announced that its U.S. subsidiary Syngenta Seeds has filed a lawsuit against Monsanto, accusing its rival of having...
SemBioSys receives United States patent for vaccine production technology.
SemBioSys reports positive preclinical results of plant produced insulin.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters